GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Other Net Income (Loss)

AWKNF (Awakn Life Sciences) Other Net Income (Loss) : $0.22 Mil (TTM As of Jul. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Other Net Income (Loss)?

Awakn Life Sciences's Other Net Income (Loss) for the three months ended in Jul. 2024 was $0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jul. 2024 was $0.22 Mil.

Awakn Life Sciences's quarterly Other Net Income (Loss) declined from Jan. 2024 ($0.22 Mil) to Apr. 2024 ($0.00 Mil) but then stayed the same from Apr. 2024 ($0.00 Mil) to Jul. 2024 ($0.00 Mil).

Awakn Life Sciences's annual Other Net Income (Loss) declined from Jan. 2022 ($0.00 Mil) to Jan. 2023 ($-3.50 Mil) but then increased from Jan. 2023 ($-3.50 Mil) to Jan. 2024 ($-1.07 Mil).


Awakn Life Sciences Other Net Income (Loss) Historical Data

The historical data trend for Awakn Life Sciences's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Other Net Income (Loss) Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Other Net Income (Loss)
- - -3.50 -1.07

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.45 - 0.22 - -

Awakn Life Sciences Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.22 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Awakn Life Sciences Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences Headlines